Russia contacts Indian Govt for Corona Vaccine: Health Ministry
Health Ministry Secretary Rajesh Bhushan said in a press conference on Tuesday that due to large scale testing, large figures are showing.
New Delhi: Health Ministry Secretary Rajesh Bhushan said in a press conference on Tuesday that due to large scale testing, large figures are showing. If the numbers are increasing then we should think about our rescue. It is important to create such an environment that people should not be afraid of testing. The mortality rate from persistent corona virus is declining.
Corona Spread in India:
It was 2.15 percent in the first week of August, which is now 1.70 percent. Maharashtra, Andhra Pradesh, Karnataka, Uttar Pradesh and Tamil Nadu account for 70 percent of the country's deaths. There are 14 states and union territories with less than 5000 corona cases.
Pandemic isn't over yet: WHO Chief
The WHO chief also said that Covid-19 has changed the picture of the world. Only from December 2019 till now its fear is increasing. During a press briefing in Geneva said that this is not the last pandemic. History is witness to many epidemics. These epidemics are the truth of life. They do not end.
NITI Aayog member Dr. VK Paul said that the vaccine developed by Russia is under consideration for the country. The Russian government has approached our government. Through our network of companies, help is sought at two levels. The third phase of vaccine manufacture in India is being studied.
Many countries of the world should conduct joint research on potential diseases vaccines and medicines. Arrangements should be made for immediate manufacture and market of vaccines and medicines so that whenever an epidemic spreads, it can be controlled immediately. No corona virus vaccine will be found by the end of this year.
Russia contacts India for vaccine:
The third phase of vaccine manufacture in India is being studied. The Government of India attaches great importance to this proposal of partnership with a special friend from this nation. The movement to manufacture vaccine in both countries is in the right direction.